Dow cutting jobs, closing plants as growth slows

NEW YORK Tue Oct 23, 2012 6:37pm EDT

Andrew Liveris, Chairman and CEO of the Dow Chemical Company, participates in a group discussion during the second day of the Clinton Global Initiative 2012 (CGI) in New York on September 24, 2012. REUTERS/Lucas Jackson

Andrew Liveris, Chairman and CEO of the Dow Chemical Company, participates in a group discussion during the second day of the Clinton Global Initiative 2012 (CGI) in New York on September 24, 2012.

Credit: Reuters/Lucas Jackson

NEW YORK (Reuters) - Dow Chemical Co (DOW.N), the largest chemical maker in the United States, said on Tuesday it plans to cut 5 percent of its workforce and shutter 20 plants as part of a restructuring program aimed at countering a slow global economy.

Dow and other chemical companies face slipping demand for products around the world. Rival DuPont (DD.N) slashed its earnings forecast and announced 1,500 jobs cuts.

"The reality is we are operating in a slow-growth environment in the near-term and, while these actions are difficult, they demonstrate our resolve to tightly manage operations..." Andrew Liveris, Dow`s chairman and chief executive, said in a statement.

The company, which hopes to save $500 million a year, said the cuts will result in a loss of around 2,400 positions worldwide.

Among its planned plant closings, Dow will shutter a high density polyethylene facility in Belgium, a sodium borhidrate plant in the Netherlands, as well as manufacturing facility in Midland, Michigan.

It will also take an unspecified charge related to its Dow Kokam LLC assets, reflecting weak demand for lithium-ion batteries.

Dow initially planned to release its restructuring plans along with its third quarter earnings on Thursday, but the news was inadvertently sent to a reporter at the Bloomberg News, according to a source on Dow's board of directors.

Dow said it will pare capital spending and investment in programs that are no longer a priority. It said those cuts should save it an additional $500 million.

The company will take fourth-quarter charges of around 50 cents to 60 cents per share for asset impairments and write-offs, severance and other costs related to the measures.

Shares of the company's fell 20 cents to $28.55 after the close of regular trading. The stock fell 4 percent in New York Stock Exchange trading.

(Additional reporting by Michael Erman in New York, Braden Reddall in San Francisco and Nichola Groom in Los Angeles. Writing by Anna Driver in Houston and editing by David Gregorio)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (2)
AlkalineState wrote:
Maybe they could go back to making napalm and agent orange. While those did not prove to be very effective at winning wars, they did generate revenue for Dow.

Oct 23, 2012 6:33pm EDT  --  Report as abuse
Crash866 wrote:
Alkaline
Do you think Dupont makes anything that has saved a life or done good for humanity…yeah I thought so…

Oct 23, 2012 8:07pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.